Skip to main content
Equibles

PTCHF · PureTech Health plc

Track PTCHF — free

Use PTCHF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PTCHF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.54 At close · Sep 23
Rebalance outlook locked
Market Cap
$375.11M
Shares
243.42M
Volume · Sep 23 500 Avg daily vol (6 sessions) 11.05K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.54 Open$1.54 Day$1.54–1.54 52W close$1.53–1.92 Avg vol 30d38K Short int60K · 0.0% float · 27.8d Short vol100% Last earningsSep 22, 2026 DataJan 2020–Sep 2026

Up next

Next earnings call
May 5, 2027 Est · unconfirmed · in 30 wks
Q2 2025 earnings call transcript
call held Jun 30, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 27.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −29%
below
Price vs 50-day avg −8%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 3%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −17%
trailing
6-month return −44%
trailing
YTD return −10%
this year
Relative strength −61%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.02% of float · ▬ 0.0% MoM · 27.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Squeeze score 41
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 87%
annualized · 1-yr
Max drawdown −57%
past year
ATR 6.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
4 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−29% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
3% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.02% of float · ▬ 0.0% MoM · 27.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2 Now $2 · 3% Range high $2
vs 200-day avg -29% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PTCHF
PureTech Health plc
this stock
$375.11M -9.6% — — 0.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
5
% held
0.1%
Net QoQ
+44.6K sh
Top holder
Pentwater Capital Managem…
Held Float
View
Short & Settlement
Short Interest
Shares short
59.9K
Days to cover
27.8d
Change
0 sh
View
Short Volume
Short vol %
100%
As of
Sep 22, 2026
Short Total
View
Fails to Deliver
FTD shares
512
Value
$7.9K
As of
Apr 8, 2026
View
Off-Exchange
Off-exchange %
99.8%
Week of
Aug 3, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
May 1, 2026
This year
4
View
Earnings & Events
Webcasts
Last webcast
Sep 22, 2026
View

Performance

5D 20D 120D MTD YTD
PTCHF -2.8% -16.7% -44.2% -1.5% -9.6%
SPY +1.8% +0.3% +17.2% +0.1% +12.6%
vs SPY -4.6% -17.0% -61.4% -1.6% -22.2%
Key facts CIK 1782999 CUSIP 746237106 Visit website Investor relations